A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
NCT07107230
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
380
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Neoplasms
Interventions
DRUG:
JNJ-95437446
Sponsor
Janssen Research & Development, LLC